首页 › 基金 › Spruce Street Capital LP › RLAY

Spruce Street Capital LP 对 RLAY 的持仓历史

RELAY THERAPEUTICS INC · 医疗保健

Spruce Street Capital LP 在 Q3 2026 的 13F 申报中披露持有 RLAY(RELAY THERAPEUTICS INC)2,984,125 股,市值约 US$53.9M,约占其申报组合的 8.56%,在其申报持仓中市值排名第 2 位。 Spruce Street Capital LP 最近 4 个申报季度中有 4 个季度披露了 RLAY 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q3 2026)2.98M 股
申报持仓市值$53.86M
组合权重8.56%
首次申报Q4 2025
最近变动持有
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Spruce Street Capital LP 对 RLAY 的持仓演变

Spruce Street Capital LP 于 Q4 2025 首次披露 RLAY 持仓:2,984,125 股(约 US$25.2M)。 该持仓在 Q2 2026 达到峰值 2,984,125 股,市值约 US$55.8M。 在 4 次申报中,Spruce Street Capital LP 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 2,984,125 股、市值约 US$53.9M。

逐季持仓明细

季度股数金额变化
Q4 2025 2.98M $25.25M 新进
Q1 2026 2.98M $29.69M 持有
Q2 2026 2.98M $55.83M 持有
Q3 2026 2.98M $53.86M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 RLAY 与 13F 数据

RLAY(RELAY THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 60 只申报持有 RLAY,申报仓位最大的包括:SB INVESTMENT ADVISERS (UK) LTD (US$522.1M), Casdin 资本 (US$300.0M), PERCEPTIVE ADVISORS LLC (US$263.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 RLAY 的基金

查看 RLAY 的全部基金持有人 →

常见问题

How long has Spruce Street Capital LP held RLAY?

Spruce Street Capital LP has disclosed RLAY holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Spruce Street Capital LP's current position in RLAY?

As of Q3 2026, Spruce Street Capital LP holds 2.98M shares of RLAY (RELAY THERAPEUTICS INC), valued at $53.86M, representing 8.56% of its reported portfolio and ranking #2.

Has Spruce Street Capital LP been buying or selling RLAY?

In the latest 13F filing (Q3 2026), Spruce Street Capital LP held unchanged its position in RLAY. The position peaked in Q2 2026 at 2.98M shares.

Which other funds hold RLAY?

Other major institutional holders of RLAY include SB INVESTMENT ADVISERS (UK) LTD, Casdin 资本, PERCEPTIVE ADVISORS LLC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.